Cannabis Stocks Soar As Government Health Officials Call On DEA To Reschedule Marijuana
According to a report by Bloomberg on Wednesday, The U.S. Department of Health and Human Services is recommending to the Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under federal law.
According to a report by Bloomberg on Wednesday, The U.S. Department of Health and Human Services is recommending to the Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under federal law. Currently, cannabis is a Schedule I drug, which deems it has no medical value and places it in the same class as dangerous drugs like heroin.
The promise of getting cannabis out of the problematic Schedule I status sent cannabis stocks soaring in a spectacular rally. Thus, AdviserShares Pure US Cannabis ETF (MSOS) was up 19.38%, while The ETFMG Alternative Harvest ETF (MJUS) rose by 12.05%.
What a Fed Rate-Hike Pause Would Mean for Bank Accounts and Loans
The Federal Reserve decided to keep interest rates the same for just the second time since beginning its current hiking cycle aimed at curbing inflation last year
Adobe Gears Up For Thursday Earnings As Options Traders Go Bullish
Adobe Inc. (ADBE) is all set to report its quarterly earnings on Sept. 14, 2023.
Wall Street Rethinks Turkish Rate Path as Inflation Heads to 70%
Wall Street banks are again having to rewrite their outlooks for Turkish interest rates, as inflation climbs faster than expected.
